BIOGENA ONE
BIOGENA ONE is a company that produces science-based nutritional supplements in the form of convenient morning drinks, manufactured in Austria.
Classification
Profile
Funding
Funding details not yet available.
Compliance
Signals
Science-based dietary supplement in a convenient, tasty morning drink format that integrates vitamins, minerals, and prebiotics for daily well-being.
Health-conscious consumers seeking easy, effective daily nutrition and well-being management through convenient supplement formats.
Direct-to-consumer sales of physical supplement products, likely via subscription or one-time purchase of the drink format.
Direct sales through their own digital platform, leveraging high customer ratings (2,000+ 5-star reviews) for acquisition.
Manufacturing partners in Austria ensuring 100% local production and quality control for the supplement formulation.
Product manufacturing, supply chain logistics, marketing to maintain high review ratings, and R&D for science-based formulations.
Proprietary science-based supplement formula, Austrian manufacturing capabilities, and a strong brand reputation evidenced by reviews.
Formulating science-based supplements, managing Austrian production, marketing the product as a convenient well-being solution.
Automated self-service via e-commerce, supported by social proof from thousands of positive customer reviews.
Competes with traditional pills and powders by offering a superior taste and convenience factor in a ready-to-drink format.
Difficulty maintaining consistent daily supplement routines and dissatisfaction with the taste or inconvenience of traditional pills.
- Publish a full clinical study on the combined formula (e.g., 12-week double-blind trial) to convert skeptics and justify the €99 price po
Scaling subscriptions will lower CAC over time, turning the high upfront marketing spend into a predictable recurring revenue engine · Strengthening scientific evidence can open doors to health-insurance reimbursement pilots in Germany and Switzerland, creating a new B2B rev · Diversifying channel mix (adding selective retail presence) mitigates DT
- Scientific backing - The formulation is created by Biogena’s in-house research team and validated by independent labs, which is a strong
No investors recorded yet.